Quantity size:
0.2ml
Concentration:
1mg/ml 胰岛素样生长因子结合蛋白7抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
IGF-BPs form high affinity complexes with both IGF-I and IGF-II and act to control of the distribution, function and activity of IGFs in various cell tissues and body fluids. There are seven named IGF-BPs. IGFBP7 plays a role in skeletal myogenesis by binding to IGF in a manner that inhibits IGF induced differentiation of skeletal myoblasts, without affecting IGF 胰岛素样生长因子结合蛋白7抗体induced proliferation. Additionally, IGFBP7 suppresses growth and colony formation of prostate and breast cancer cell lines through an IGF independent mechanism, which causes a delay in the G1 phase of the cell cycle, and increased apoptosis. IGFBP7 is expressed in a wide range of normal human tissues and it usually shows reduced expression in cancer cell lines of prostate, breast, colon, and lung origin.
胰岛素样生长因子结合蛋白7抗体Also known as:
AGM; Angiomodulin; FSTL2; IBP-7; IBP7; IBP7_HUMAN; IGF binding protein 7; IGF-binding protein 7; IGFBP rP1; IGFBP-7; IGFBP-rP1; IGFBP7; IGFBPRP1; Insulin like growth factor binding protein 7; Insulin-like growth factor-binding protein 7; MAC25; MAC25 protein; PGI2 stimulating factor; PGI2-stimulating factor; Prostacyclin stimulating factor; 胰岛素样生长因子结合蛋白7抗体Prostacyclin-stimulating factor; PSF; RAMSVPS; TAF; Tumor-derived adhesion factor.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human IGFBP7 (.
●
胰岛素样生长因子结合蛋白7抗体Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl728Hu01生长分化因子2(GDF2)多克隆抗体Polyclonal Antibody to Growth Differentiation Factor 2 (GDF2)
kl728Mu01生长分化因子2(GDF2)多克隆抗体Polyclonal Antibody to Growth Differentiation Factor 2 (GDF2)
kl729Hu01癌蛋白诱导转录物3(OIT3)多克隆抗体Polyclonal Antibody to Oncoprotein Induced Transcript 3 (OIT3)
kl735Hu01胱天蛋白酶4(CASP4)多克隆抗体Polyclonal Antibody to Caskle 4 (CASP4)
kl737Hu01信号传导转录激活因子6(STAT6)多克隆抗体Polyclonal Antibody to Signal Transducer And Activator Of Transcription 6 (STAT6)
kl744Hu01泛素D(UBD)多克隆抗体Polyclonal Antibody to Ubiquitin D (UBD)
kl745Hu01血小板型磷酸果糖激酶(PFKP)多克隆抗体Polyclonal Antibody to Phosphofructokinase, Platelet (PFKP)
kl750Hu01肿瘤坏死因子配体超家族成员13(TNFSF13)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)
kl750Mu01肿瘤坏死因子配体超家族成员13(TNFSF13)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)
kl752Hu01Ⅰ类主要组织相容性复合体E(MHCE)多克隆抗体Polyclonal Antibody to Major Histocomklibility Complex Class I E (MHCE)
kl753Hu01谷氨酸受体相互作用蛋白1(GRIP1)多克隆抗体Polyclonal Antibody to Glutamate Receptor Interacting Protein 1 (GRIP1)
kl756Hu01表皮转谷氨酰胺酶(TGM3)多克隆抗体Polyclonal Antibody to Transglutaminase 3, Epidermal (TGM3)
kl757Hu01肌动蛋白束蛋白(FSCN)多克隆抗体Polyclonal Antibody to Fascin (FSCN)
kl758Hu01核糖核酸酶A3(RNASE3)多克隆抗体Polyclonal Antibody to Ribonuclease A3 (RNASE3)
kl759Hu01羟甲基戊二酰辅酶A合酶(HMGCS)多克隆抗体Polyclonal Antibody to Hydroxymethylglutaryl Coenzyme A Synthase (HMGCS)
kl760Hu01再生胰岛衍生蛋白1α(REG1α)多克隆抗体Polyclonal Antibody to Regenerating Islet Derived Protein 1 Alpha (REG1a)
kl760Ra01再生胰岛衍生蛋白1α(REG1α)多克隆抗体Polyclonal Antibody to Regenerating Islet Derived Protein 1 Alpha (REG1a)
kl761Hu01抑瘤素M受体(OSMR)多克隆抗体Polyclonal Antibody to Oncostatin M Receptor (OSMR)
kl762Hu01抑制素βB(INHβB)多克隆抗体Polyclonal Antibody to Inhibin Beta B (INHbB)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话